SAN FRANCISCO (GenomeWeb) - The 36th annual JP Morgan Healthcare Conference kicked off here on Monday with some of the life science tools and molecular diagnostics industries heavyweights presenting. Below are brief reports on the presentations and breakout sessions covered by our team at the conference.

Genomic Health

Following an expected profitable 2017, Genomic Health CEO Kim Popovits said that the company expects to record another profit in 2018 fueled by anticipated double-digit growth in 2018 revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.